Frontiers in Cardiovascular Medicine

APRIL 18, 2024

Improvements in exercise tolerance, lipid metabolism, cardiac function, and psychological aspects of the patients were evident with appropriate exercise interventions based on a comprehensive assessment. Aerobic exercise, resistance training, flexibility training, and other forms of exercise are recommended by many experts.

Cardiac Rehabilitation 40

Cardiac Rehabilitation Research Quality of Life Exercise 40

Journal of Cardiovascular Pharmacology

FEBRUARY 11, 2024

Myocardial fibrosis, a common complication of myocardial infarction (MI), is characterized by excessive collagen deposition and can result in impaired cardiac function. Remarkably, CD137 knockout mice exhibited improved cardiac function and reduced fibrosis compared to wild-type mice at day 28 post-MI.

Cardiac Function 40

Cardiac Function Myocardial Infarction Article 40

Journal of Cardiovascular Electrophysiology

JANUARY 29, 2025

LBBP significantly improved cardiac function at 1week of follow-up. Whether these RWA changes, through enhancing whole myocardial contractility, have a synergistic effect with LBBP synchronization to further improve cardiac function remains to be investigated.

Cardiac Function 40

Cardiac Function Pacemaker Physiology Outcomes 40

Journal of Cardiovascular Pharmacology

MARCH 18, 2025

Furthermore, TMAO was observed to impair murine cardiac function. Furthermore, TMAO was observed to impair murine cardiac function. In the mouse TAA model, TMAO exacerbates aortic dilation and degeneration, promoting the development of thoracic aortic aneurysm.

Aneurysm 40

Aneurysm Aortic Cardiac Function Cardiovascular Disease 40

Journal of Cardiovascular Pharmacology

AUGUST 12, 2024

Furthermore, the differential expression of AMPK/PINK1/Parkin pathway-related proteins in ISO-induced cardiac remodeling was effectively reversed by canagliflozin, suggesting the therapeutic potential of targeting this pathway with the drug. Heart failure has always been a prevalent, disabling, and potentially life-threatening disease.

Heart Failure 40

Heart Failure Cardiac Function Research Article 40

Journal of Cardiovascular Pharmacology

JULY 23, 2024

Serial echocardiography and pressure-volume loops were utilized to assess cardiac function and hemodynamics. Serial echocardiography and pressure-volume loops were utilized to assess cardiac function and hemodynamics. In contrast, combination therapy resulted in significant improvement.

Bicuspid/Mitral 40

Bicuspid/Mitral Cardiac Function Heart Failure Circulation 40

Journal of Cardiovascular Pharmacology

FEBRUARY 28, 2024

Here, we performed transcriptome analysis of SNPiP-treated mice ventricles to elucidate how SNPiP exerts beneficial effects on cardiac function. Here, we performed transcriptome analysis of SNPiP-treated mice ventricles to elucidate how SNPiP exerts beneficial effects on cardiac function.

Cardiac Function 40

Cardiac Function Ischemia Article 40

Journal of Cardiovascular Pharmacology

NOVEMBER 16, 2023

Overexpression of ALKBH5 inhibited H/R-induced cardiomyocyte apoptosis and oxidative stress in vitro, and inhibited I/R-induced collagen deposition, cardiac function, and apoptosis in vivo. We observed that ALKBH5 and MG53 were highly expressed in MI. We observed that ALKBH5 and MG53 were highly expressed in MI.

Myocardial Infarction 40

Myocardial Infarction Cardiac Function Ischemia Article 40

Journal of Cardiovascular Pharmacology

MARCH 13, 2024

Data express a benefit of SFN treatment on the cardiac function of rats with PAH associated with the cellular redox state. Data express a benefit of SFN treatment on the cardiac function of rats with PAH associated with the cellular redox state. Catalase and GSH/GSSG ratio were diminished in MCT compared to CTR (P<0.05).

Pulmonary 40

Pulmonary Hypertension Tricuspid Cardiac Function 40

Journal of Cardiovascular Pharmacology

MARCH 24, 2024

We found that RUS effectively alleviated myocardial pathological damage, normalized cardiac function, and increased survival in septic mice. We found that RUS effectively alleviated myocardial pathological damage, normalized cardiac function, and increased survival in septic mice.

Cardiac Function 40

Cardiac Function Article 40

Journal of Cardiovascular Pharmacology

APRIL 4, 2024

PTE administration promoted protective effects in terms of oxidative stress in two experimental models of cardiac diseases: MI and PAH. PTE also improved cardiac function in infarcted rats and pulmonary artery flow in animals with PAH. In the PAH model, PTE improved pulmonary artery flow and decreased ROS levels in the lung.

Myocardial Infarction 40

Myocardial Infarction Cardiovascular Disease Pulmonary Hypertension 40

Journal of Cardiovascular Pharmacology

NOVEMBER 22, 2023

Echocardiography was used to estimate cardiac function. Echocardiography was used to estimate cardiac function. After 6 weeks, some WT mice (n=24) in CIH group were given sildenafil or saline gavage for another 4 weeks. Blood pressure was regularly measured during the experiment.

Blood Pressure 40

Blood Pressure Cardiac Function Article 40

Journal of Cardiovascular Electrophysiology

MARCH 3, 2024

Abstract Introduction Cardiac contractility modulation (CCM) is a medical device-based therapy delivering non-excitatory electrical stimulations to the heart to enhance cardiac function in heart failure (HF) patients. The lack of human in vitro tools to assess CCM hinders our understanding of CCM mechanisms of action.

Cardiac Function 40

Cardiac Function Electrophysiology Physiology Heart Failure 40

European Journal of Heart Failure

OCTOBER 17, 2023

Associations with incident heart failure (HF) and with cardiac function using Cox proportional hazards regression and linear regression models, respectively. A protein-based neutrophil activity score was derived from 10 candidate proteins using LASSO Cox regression.

Heart Failure 40

Heart Failure Preserved Ejection Fraction Circulation Pharmacology 40

Conquering CHD

JUNE 20, 2023

Cardiac Glycosides WHAT THEY DO : Cardiac glycosides improve cardiac function in children with CHD. They act by controlling numerous functions of the cardiovascular system, including to help slow down the heartbeat and increase the strength of each contraction.

Congenital Heart Disease 52

Congenital Heart Disease Congenital Heart Disease ACE Inhibitor 52

European Journal of Heart Failure

JANUARY 21, 2024

Our study aimed to evaluate the expression of sodium–glucose cotransporter 2 (SGLT2) gene and protein in patients with severe AS stratified in high gradient (HG) and low flow-low gradient (LF-LG) AS and its association with cardiac functional impairments.

Stenosis 40

Stenosis Aortic Aortic valve Coronary Artery Disease 40

The British Journal of Cardiology

AUGUST 6, 2024

However, its impact on cardiac structure and function using echocardiography, as well as its association with anthropometric parameters in otherwise healthy individuals, requires further investigation. Obesity is a global pandemic and is a recognised risk factor for cardiovascular diseases.

Obesity 40

Obesity Risk Factors Cardiovascular Disease Cardiac Function 40

European Journal of Heart Failure

NOVEMBER 28, 2024

Relationships with rest/exercise measures of cardiac function and congestion using ultrasound, effort intolerance and adverse outcome (HF hospitalizations or all-cause mortality) were assessed. Alternative ID definitions based on TSAT (<20%), iron (13 mol/L), and ferritin (<100 or<300ng/ml) were explored.

Heart Failure 40

Heart Failure Cardiac Function Exercise Ultrasound 40

Dr. Smith's ECG Blog

JULY 21, 2024

Cardiac function is poor, with akinesis of the LAD territory. baseline (this is what most recommend but seems like far too much QRS widening to me) = See these articles and this graphic: 1. The echo images below were obtained on the day of presentation after PCI. This was recorded a number of days later ).

Arrhythmia 131

Arrhythmia Cardiogenic Shock Bradycardia Defibrillator 131

Cardiomatics

FEBRUARY 9, 2022

Cardiac resynchronization therapy (CRT) exists as an option for patients with heart failure with reduced ejection fraction (HFrEF), for whom pharmacotherapy alone is insufficient to reduce symptoms and control cardiac function [2].

Heart Failure 52

Heart Failure Myocardial Infarction Medicare Defibrillator 52

European Journal of Heart Failure

NOVEMBER 26, 2024

Abstract Aims Traditional cardiovascular (CV) biomarkers (high-sensitivity troponinT [hsTnT] and N-terminal pro-B-type natriuretic peptide [NT-proBNP]) are important to monitor cancer patients' cardiac function and to assess prognosis.

Biomarkers 40

Biomarkers Cancer Laboratory Cardiac Function 40

Frontiers in Cardiovascular Medicine

OCTOBER 31, 2024

ResultsA total of 25 articles were ultimately included in the analysis. Based on these results, it is recommended that cardiac function be closely monitored in patients with reduced IGF-1 levels and in those with acromegaly. The outcomes were analyzed using RevMan 5.4 and STATA 15.ResultsA to −3.97; p = 0.02).

Heart Failure 52

Heart Failure Cardiac Function Biomarkers Article 52

Frontiers in Cardiovascular Medicine

DECEMBER 8, 2024

SGLT2 inhibitors could improve cardiac function through potential non-hypoglycemic mechanisms, including the reduction of the circulatory volume load, regulation of energy metabolism, maintenance of ion homeostasis, alleviation of inflammation and oxidative stress, and direct inhibition of cardiac SGLT1 receptors and antimyocardial fibrosis.

Heart Failure 40

Heart Failure Cardiac Function Article Diabetes 40